Mannkind website names Leerink Swann (I think Seamus Fernandez) as one of the analysts coverage, but Leerink website has suspended coverage on us...

I have sent a mail to Seamus Fernandez asking for explanation. He was present at the Q2 CC and had questions during Q&A. Would appreciate if others on the board contact him to get clarification as well, helps to build the momentum :-)

p.s. Seamus is a top 3 ranked analyst in the Pharma sector for like 4 yrs in a row, would be valuable to get his input.